These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child. Uebe B; Sauerbrei A; Burdach S; Horneff G Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208 [TBL] [Abstract][Full Text] [Related]
5. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus. Lässker U; Harder TC; Hufnagel M; Suttorp M Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096 [TBL] [Abstract][Full Text] [Related]
6. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409 [TBL] [Abstract][Full Text] [Related]
7. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. Levin MJ; DeBiasi RL; Bostik V; Schmid DS J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373 [TBL] [Abstract][Full Text] [Related]
8. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child. Han JY; Hanson DC; Way SS Pediatr Infect Dis J; 2011 Mar; 30(3):266-8. PubMed ID: 20844461 [TBL] [Abstract][Full Text] [Related]
9. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. Sauerbrei A; Wutzler P J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537 [TBL] [Abstract][Full Text] [Related]
10. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method. Tang YW; Allawi HT; DeLeon-Carnes M; Li H; Day SP; Schmid D J Clin Virol; 2007 Oct; 40(2):129-34. PubMed ID: 17728179 [TBL] [Abstract][Full Text] [Related]
11. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487 [TBL] [Abstract][Full Text] [Related]
13. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. Quinlivan ML; Gershon AA; Steinberg SP; Breuer J J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408 [TBL] [Abstract][Full Text] [Related]
14. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413 [TBL] [Abstract][Full Text] [Related]
15. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. Lopez AS; Burnett-Hartman A; Nambiar R; Ritz L; Owens P; Loparev VN; Guris D; Schmid DS J Infect Dis; 2008 Mar; 197(5):646-53. PubMed ID: 18260757 [TBL] [Abstract][Full Text] [Related]
16. Herpes zoster in childhood. Leung AK; Robson WL; Leong AG J Pediatr Health Care; 2006; 20(5):300-3. PubMed ID: 16962434 [TBL] [Abstract][Full Text] [Related]